IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma

Chunbao Zang; Xujie Liu; Bing Li; Yanqiong He; Shen Jing; Yujia He; Wenli Wu; Bingqian Zhang; Shuhong Ma; Weiwei Dai; Shaolin Li; Zhiping Peng

doi:10.18632/oncotarget.14495

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma

Chunbao Zang, Xujie Liu, Bing Li, Yanqiong He, Shen Jing, Yujia He, Wenli Wu, Bingqian Zhang, Shuhong Ma, Weiwei Dai, Shaolin Li and Zhiping Peng _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:11228-11238. https://doi.org/10.18632/oncotarget.14495

Metrics: PDF 3293 views | HTML 3270 views | ?

Abstract

Chunbao Zang1,*, Xujie Liu1,*, Bing Li2,*, Yanqiong He1, Shen Jing1, Yujia He1, Wenli Wu1, Bingqian Zhang1, Shuhong Ma1, Weiwei Dai1, Shaolin Li1, Zhiping Peng1

1Department of Radiological Medicine, Chongqing Medical University, Chonging, China

2Department of Otorhinolaryngology, The First Affiliated Hospital of Chonqqing Medical University, Chongqing, China

*These authors contributed equally to this work

Correspondence to:

Zhiping Peng, email: [email protected]

Keywords: radioresistance, EMT, IL-6/STAT3/TWIST pathway

Received: July 25, 2016 Accepted: December 27, 2016 Published: January 04, 2017

ABSTRACT

The acquisition of radioresistance by esophageal squamous carcinoma (ESC) cells during radiotherapy may lead to cancer recurrence and poor survival. Previous studies have demonstrated that ionizing radiation (IR) induces epithelial–mesenchymal transition (EMT) of ESC cells accompanied by increased migration, invasion, and radioresistance. However, the underlying molecular mechanisms of IR-induced EMT and radioresistance are not well established, hampering the development of potential solutions. To address this issue, we investigated the role of the IL-6/STAT3/TWIST signaling pathway in IR-induced EMT. We found not only the pathway was activated during IR-induced EMT but also STAT3 inhibition or Twist depletion reversed the EMT process and attenuated radioresistance. These results improve our understanding of the underlying mechanisms involved in IR-induced EMT and suggest potential interventions to prevent EMT-induced acquisition of radioresistance.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 14495

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma

Abstract